SAN ANTONIO--(BUSINESS WIRE)--Dec 12, 2024--. bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need ...
News
- bioAffinity Technologies Set for Continued Expansion in 2025 | News | bakersfield.com
- ALX Oncology to Host Virtual Company Event Highlighting New Clinical Data Presented at ...
... biotechnology company advancing therapies that ... The data were featured today in a spotlight poster presentation at the 2024 San Antonio Breast Cancer ...
- Ibrance combination extends median PFS in breast cancer group | The Pharmaletter
12 December 2024. More on this story... Pfizer's rollercoaster ride and what comes next · Biotechnology.
- US appeals court rejects Nasdaq's diversity rules for company boards
Brooklynn Chandler Willy, CEO and president of San Antonio-based Texas Financial Advisory,. Business · IRS arrests S.A. investment adviser, radio host ...
- TerSera® Presents New Real-World Evidence on Treatment Outcomes of Goserelin ... - BioSpace
These data were presented in a poster session at the 2024 San Antonio Breast Cancer Symposium, held December 10-13 in San Antonio, TX.1 A copy of ...